Equities

Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)21.48
  • Today's Change0.36 / 1.70%
  • Shares traded863.67k
  • 1 Year change+54.98%
  • Beta0.7470
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue398214141
OPERATING EXPENSES
Cost of revenue total523422
Selling, general and admin. expenses, total1345850
Depreciation/amortization33----
Unusual expense(income)------
Other operating expenses, total------
Total operating expense31111288
Operating income8710252
Other, net7.702.880.28
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes9510553
Provision for income taxes232213
Net income after taxes718339
Minority interest------
Net income before extra. Items718339
Total extraordinary items------
Net income718339
Inc.avail. to common excl. extra. Items718339
Inc.avail. to common incl. extra. Items718339
EPS RECONCILIATION
Basic/primary weighted average shares106103103
Basic/primary eps excl. extra items0.670.800.38
Basic/primary eps incl. extra items0.670.800.38
Dilution adjustment------
Diluted weighted average shares114111108
Diluted eps excl. extra items0.630.750.37
Diluted eps incl. extra items0.630.750.37
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental0.320.140.19
Total special items------
NORMALISED INCOME
Normalized income before taxes9510553
Effect of special items on income taxes------
Income tax excluding impact of special items232213
Normalized income after tax718339
Normalized income avail. to common718339
Basic normalized EPS0.670.800.38
Diluted normalized EPS0.630.750.37
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.